Published in Infect Immun on November 01, 1973
Induction of interferon in ovine and human lymphocyte cultures by mycoplasmas. Infect Immun (1976) 1.24
Induction of a pH-stable interferon in sheep lymphocytes by Mycoplasmatales virus MVL2. Infect Immun (1978) 0.97
Induction of interferon in mice by mycoplasmas. Infect Immun (1974) 0.97
Viral replication and interferon production in fetal and adult ovine leukocytes and spleen cells. Infect Immun (1975) 0.97
Fetal and adult bovine interferon production during bovine viral diarrhea virus infection. Infect Immun (1976) 0.94
Mycoplasma-mediated hyporeactivity to various interferon inducers. Infect Immun (1975) 0.83
Interferon induction in bovine and feline monolayer cultures by four bluetongue virus serotypes. Can J Comp Med (1982) 0.82
I-E/I-C region-associated induction of murine gamma interferon by a haplotype-restricted polyclonal T-cell mitogen derived from Mycoplasma arthritidis. Infect Immun (1984) 0.80
Mycoplasma interaction with lymphocytes and phagocytes: role of hydrogen peroxide released from M. pneumoniae. Yale J Biol Med (1984) 0.76
H2 gene control and biological activities of a T-cell mitogen derived from Mycoplasma arthritidis: a review. Yale J Biol Med (1984) 0.75
Tissue cultures and mycoplasmas. Tex Rep Biol Med (1965) 17.31
Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc Natl Acad Sci U S A (1962) 14.59
A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J Hyg (Lond) (1966) 6.23
SEROLOGICAL RELATIONSHIPS AMONG HUMAN MYCOPLASMAS AS SHOWN BY COMPLEMENT-FIXATION AND GEL DIFFUSION. J Bacteriol (1963) 4.45
Immune specific induction of interferon production in cultures of human blood lymphocytes. Science (1969) 4.43
The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells. J Exp Med (1971) 2.92
Growth inhibition test for identification of Mycoplasma species utilizing dried antiserum-impregnated paper discs. J Bacteriol (1967) 2.83
Mycoplasmas and cell cultures. Bacteriol Rev (1971) 2.41
Isolation of Mycoplasmatales viruses and characterization of MVL1, MVL52, and MVG51. Science (1971) 2.07
Effect of Animal Passage on Arthritogenic and Biological Properties of Mycoplasma arthritidis. Infect Immun (1970) 2.00
Mycoplasmatales virus-laidlawii 2, a new virus isolated from Acholeplasma laidlawii. J Gen Virol (1971) 1.91
Isolation of a virus infecting a strain of Mycoplasma laidlawii. Nature (1970) 1.87
Isolation and identification of mycoplasma from human clinical materials. Ann N Y Acad Sci (1967) 1.79
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Physiocochemical and serological studies. J Gen Virol (1971) 1.78
Interaction of Mycoplasma arthritidis and other mycoplasmas with murine peritoneal macrophages. Infect Immun (1973) 1.74
The interaction of mycoplasmas with mammalian cells. II. Monocytes and lymphocytes. J Exp Med (1966) 1.57
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies. J Gen Virol (1971) 1.56
Current concepts of interferon and interferon induction. Annu Rev Med (1970) 1.53
The interaction in vitro between polymorphonuclear leukocytes and mycoplasma. J Exp Med (1971) 1.50
THE OCCURRENCE OF MYCOPLASMA (PLEUROPNEUMONIA-LIKE ORGANISMS, PPLO) IN THE ORAL CAVITY OF DENTULOUS AND EDENTULOUS SUBJECTS. J Dent Res (1964) 1.45
Electron microscopic studies of Mycoplasma (PPLO strain 880) in artificial medium and in tissue culture. J Natl Cancer Inst (1966) 1.23
Cell interaction with a synthetic polynucleotide and interferon production in vitro. Virology (1969) 1.13
Transfection mediated by Mycoplasmatales viral DNA. Proc Natl Acad Sci U S A (1972) 1.11
Investigations into the influence of the galactan of Mycoplasma mycoides on experimental infection with that organism. J Pathol Bacteriol (1967) 1.09
The interferons and their inducers: molecular and therapeutic considerations. 1. N Engl J Med (1972) 1.01
Bluetongue virus. Virol Monogr (1971) 0.95
Observations on mycoplasma strains in tissue cultures. Ann N Y Acad Sci (1967) 0.94
Effect of mycoplasma on interferon production and interferon assay in cell cultures. J Bacteriol (1966) 0.94
Morphological and quantitative aspects of mycoplasma-human cell relationships. Proc Soc Exp Biol Med (1967) 0.93
Enhanced virus yields and decreased interferon production in mycoplasma-infected hamster cells. Proc Soc Exp Biol Med (1969) 0.92
Transmission of Mycoplasma gallisepticum, Newcastle disease, infectious bronchitis, and combinations in a three-phase broiler house. Avian Dis (1969) 0.87
Serology and gross lesions of turkeys inoculated with an avian influenza A virus, a paramyxovirus, and Mycoplasma gallisepticum. Avian Dis (1970) 0.86
The results of some comparative experimental investigations of L-forms of bacteria and mycoplasma. Ann N Y Acad Sci (1967) 0.86
[Effect of mycoplasma-viral infection of a primary culture of chick embryo cells on interferon production induced by Langat virus]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.84
Human leukocyte interferon: the variation in normals and correlation with PHA transformation. 1. Proc Soc Exp Biol Med (1972) 0.83
Mycoplasma laidlawii in human burns. J Bacteriol (1969) 0.82
The influence of mycoplasma infection on the sensitivity of HeLa cells for growth of viruses. J Med Microbiol (1970) 0.82
Interferon-like inhibitor produced in bovine leukocyte cultures after inoculation with endotoxin. (Brief report). Arch Gesamte Virusforsch (1967) 0.79
Interferon and its inducers: antiviral and other effects. CRC Crit Rev Clin Lab Sci (1972) 0.77
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol (1987) 17.36
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol (1999) 10.41
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med (1995) 6.90
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
The staphylococcal scalded-skin syndrome. N Engl J Med (1970) 5.33
Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study. Lancet (1987) 4.33
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis (2000) 3.73
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med (1977) 3.61
The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin. J Infect Dis (1972) 3.45
The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med (1992) 3.32
Mycoplasmas as agents of human disease. N Engl J Med (1981) 3.28
Cellular immunity in host resistance to viral infections. Arch Intern Med (1970) 2.79
Leukocytes and interferon in the host response to viral infections. II. Enhanced interferon response of leukocytes from immune animals. J Bacteriol (1966) 2.78
Neonatal bacterial meningitis. Analysis of predisposing factors and outcome compared with matched control subjects. J Pediatr (1970) 2.62
Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J Infect Dis (1973) 2.53
Chronic proliferative arthritis of mice induced by Mycoplasma arthritidis. I. Induction of disease and histopathological characteristics. Infect Immun (1971) 2.51
Opportunistic lung infection due to "Pittsburgh Pneumonia Agent". N Engl J Med (1979) 2.49
New bacterial agent of pneumonia isolated from renal-transplant recipients. Lancet (1979) 2.45
Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men. Ann Intern Med (1989) 2.44
Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis (1980) 2.41
Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J Infect Dis (1977) 2.30
Variables influencing condom use in a cohort of gay and bisexual men. Am J Public Health (1988) 2.26
Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus. J Bacteriol (1974) 2.23
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study. Ann Intern Med (1988) 2.18
Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis (1982) 2.16
Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr (2000) 2.13
Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol (1999) 2.11
Staphylococcal scalded skin syndrome: the expanded clinical syndrome. J Pediatr (1971) 2.11
Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA (1989) 2.09
Rapid detection of herpes simplex virus in clinical specimens by centrifugation and immunoperoxidase staining. J Clin Microbiol (1986) 2.06
Effect of Animal Passage on Arthritogenic and Biological Properties of Mycoplasma arthritidis. Infect Immun (1970) 2.00
Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA (1990) 2.00
The course of untreated recurrent genital herpes simplex infection in 27 women. N Engl J Med (1981) 1.89
Isolation of extrachromosomal deoxyribonucleic acid for exfoliative toxin production from phage group II Staphylococcus aureus. J Bacteriol (1975) 1.88
Interferon and cytomegalovirus in vivo and in vitro. Proc Soc Exp Biol Med (1967) 1.85
AIDS prevention in homosexual and bisexual men: results of a randomized trial evaluating two risk reduction interventions. AIDS (1989) 1.80
Immunological responses of the rat to Mycoplasma arthritidis. J Bacteriol (1969) 1.80
A comparative study on the virulence of Mycoplasma arthritidis and "Mycoplasma hominis, type 2" strains in rats. Proc Soc Exp Biol Med (1967) 1.78
Role of Biological Mimicry in the Pathogenesis of Rat Arthritis Induced by Mycoplasma arthritidis. Infect Immun (1971) 1.75
Interaction of Mycoplasma arthritidis and other mycoplasmas with murine peritoneal macrophages. Infect Immun (1973) 1.74
Characterization of mycoplasma strains from cats. J Bacteriol (1967) 1.72
Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis (1982) 1.72
Arthritis of mice induced by Mycoplasma pulmonis: humoral antibody and lymphocyte responses of CBA mice. Infect Immun (1975) 1.70
Hemolysin and peroxide activity of Mycoplasma species. J Bacteriol (1968) 1.69
Replication of herpes simplex virus and cytomegalovirus in human leukocytes. J Immunol (1978) 1.69
Effect of ethidium bromide on elimination of exfoliative toxin and bacteriocin production in Staphylococcus aureus. J Bacteriol (1974) 1.69
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci U S A (1996) 1.68
No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr (1990) 1.67
Clustering of necrotizing enterocolitis. Interruption by infection-control measures. N Engl J Med (1977) 1.67
Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology (1993) 1.67
Phage group II staphylococcal strains with chromosomal and extrachromosomal genes for exfoliative toxin production. Infect Immun (1976) 1.66
Bacterial tracheitis. JAMA (1979) 1.64
The HIV antibody test: why gay and bisexual men want or do not want to know their results. Public Health Rep (1987) 1.62
Factors modifying host resistance to viral infection. 3. Effect of whole body x-irradiation on experimental encephalomyocarditis virus infection in mice. J Exp Med (1968) 1.61
Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphate. J Infect Dis (1977) 1.60
Infant botulism: clinical spectrum and epidemiology. Pediatrics (1980) 1.58
Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol (1991) 1.57
Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology (1998) 1.57
Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid. Antimicrob Agents Chemother (1978) 1.57
Differential susceptibility of male and female mice to encephalomyocarditis virus: effects of castration, adrenalectomy, and the administration of sex hormones. Infect Immun (1972) 1.56
Immunologic responses to Hemophilus influenzae meningitis. J Pediatr (1972) 1.53
Mycoplasma infections as models of chronic joint inflammation. Arthritis Rheum (1979) 1.51
Nosocomial infections in a newborn intensive-care unit. Results of forty-one months of surveillance. N Engl J Med (1976) 1.50
Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA (1987) 1.49
Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon. J Natl Cancer Inst (1978) 1.49
Dendritic cells are potent antigen-presenting cells for microbial superantigens. J Exp Med (1992) 1.48
Resistance to HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1994) 1.47
Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis (1979) 1.46
Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood (2001) 1.45
Screening for Chlamydia trachomatis infection in college women with a polymerase chain reaction assay. Clin Infect Dis (1999) 1.44
Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections. Infect Immun (1976) 1.44
Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol (1996) 1.42
Comparison of antiviral and antitumor activity of activated macrophages. Cell Immunol (1977) 1.42
Genital herpesvirus hominis infection in mice. I. Development of an experimental model. Infect Immun (1975) 1.41
More rapid isolation of herpes simplex virus in a continuous line of mink lung cells than in Vero or human fibroblast cells. Diagn Microbiol Infect Dis (1984) 1.39
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. AIDS Res Hum Retroviruses (1990) 1.39
Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol (1987) 1.37
Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza. J Infect Dis (1968) 1.36
Chronic arthritis of rabbits induced by mycoplasmas. I. Clinical microbiologic, and histologic features. Arthritis Rheum (1980) 1.35
Marketing strategies for recruiting gay men into AIDS research and education projects. J Community Health (1986) 1.35
Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. V. A small basic protein from culture supernatants is a potent T cell mitogen. J Immunol (1986) 1.34
CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol (1994) 1.32
Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus. J Infect Dis (1977) 1.32
Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol (2000) 1.32
The effect of group education on improving attitudes about AIDS risk reduction. N Y State J Med (1987) 1.32
Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infection. J Infect Dis (1981) 1.29
Tilorone hydrochloride: an oral interferon-inducing agent. Antimicrob Agents Chemother (1972) 1.28
Transfer of interferon-producing macrophages: new approach to viral chemotherapy. Science (1970) 1.27
Human polymorphonuclear leukocyte interaction with cyclosporine A. Infect Immun (1984) 1.27